TherapeuticsMD reported $1.41M in Operating Expenses for its fiscal quarter ending in June of 2024.





Operating Expenses Change Date
AbbVie USD 10.52B 258M Sep/2026
Alterity Therapeutics Limited AUD 8.67M 893.38K Dec/2025
Cipla INR 63.61B 1.3B Sep/2026
Clal Biotechnology ILS 5.15M 9.47M Dec/2022
Compugen USD 11.44M 246K Jun/2026
CSL USD 5.7B 2.82B Dec/2025
Grifols EUR 1.99B 217.4M Dec/2025
Novo Nordisk DKK 6.96B 30.25B Jun/2026
Pfizer USD 89B 3.81B Sep/2026
TherapeuticsMD USD 1.41M 50K Jun/2024